Christina Yu

Director/Senior Director, Head of Isotope Chemistry at AstraZeneca

Director with experience in managing a global group of radiochemists at two sites in two countries giving support to 3 major sites in three countries. Radiochemist with expertise in the synthesis of radioactive compounds labeled with C-14, H-3 and S-35 and stable isotope labeled compounds labeled with H-2, C-13 and N-15. Have also designed PET ligands, prepared the PET ligand precursors, and assisted in the design of PET studies. Have inteacted with Drug metabolism to assist in the identification and confirmation of metabolites. Extensive experience with the out sourcing of syntheses. Specialties: Organic synthesis. Radiochemistry, Outsourcing.